Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-01-14 Bertrand William C JR Chief Operating Officer Sale −2,271 $5.37 $12K 3,731
2019-01-14 Amado Rafael President, R & D Sale −3,028 $5.37 $16K 4,974
2019-01-14 Rawcliffe Adrian Chief Financial Officer Sale −3,084 $5.37 $17K 3,318
2018-10-01 Binder-Scholl Gwendolyn Knowlton Chief Technology Officer Sale −25,000 $13.79 $345K 0
2018-08-29 Binder-Scholl Gwendolyn Knowlton Chief Technology Officer Sale −25,000 $10.25 $256K 0
2018-06-06 Thompson Peter A. Director Sale −1,600 $13.49 $22K 4,901,310
2018-06-06 ORBIMED ADVISORS LLC Director Sale −1,600 $13.49 $22K 4,901,310
2018-06-04 Thompson Peter A. Director Sale −17,100 $13.57 $232K 4,902,910
2018-06-04 ORBIMED ADVISORS LLC Director Sale −17,100 $13.57 $232K 4,902,910
2018-06-01 Thompson Peter A. Director Sale −50,000 $13.49 $675K 4,920,010
2018-06-01 ORBIMED ADVISORS LLC Director Sale −50,000 $13.49 $675K 4,920,010
2018-05-30 Thompson Peter A. Director Sale −121,000 $13.52 $1.6M 4,970,010
2018-05-30 ORBIMED ADVISORS LLC Director Sale −121,000 $13.52 $1.6M 4,970,010
2018-05-14 Thompson Peter A. Director Sale −10,300 $13.50 $139K 5,091,010
2018-05-14 ORBIMED ADVISORS LLC Director Sale −10,300 $13.50 $139K 5,091,010
2018-03-29 Thompson Peter A. Director Sale −31,983 $11.53 $369K 5,101,310
2018-03-29 ORBIMED ADVISORS LLC Director Sale −31,983 $11.53 $369K 5,101,310
2018-03-27 Thompson Peter A. Director Sale −1,016,084 $11.50 $11.7M 5,133,293
2018-03-27 ORBIMED ADVISORS LLC Director Sale −1,016,084 $11.50 $11.7M 5,133,293
2018-03-20 Rawcliffe Adrian Chief Financial Officer Sale −600,000 $1.71 $1.0M 0

Page 7 of 7 · 140 trades